Günal Özgür, M. Çetin, T. Telli, D. Filinte, I. Tinay
{"title":"肾细胞癌的睾丸转移","authors":"Günal Özgür, M. Çetin, T. Telli, D. Filinte, I. Tinay","doi":"10.4274/jus.galenos.2022.2022.0002","DOIUrl":null,"url":null,"abstract":"We report on a patient, who was diagnosed with renal cell carcinoma (RCC) and presented with testicular metastasis at 5 years after the initial diagnosis, surgical interventions and systemic treatments. Although there are reports of testicular metastasis of RCC, to the best of our knowledge, our case is first who presented late recurrence in the testicular tissue despite previous tyrosine kinase inhibitor and PD1 inhibitor treatments.","PeriodicalId":42050,"journal":{"name":"Journal of Urological Surgery","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Testicular Metastasis in Renal Cell Carcinoma\",\"authors\":\"Günal Özgür, M. Çetin, T. Telli, D. Filinte, I. Tinay\",\"doi\":\"10.4274/jus.galenos.2022.2022.0002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We report on a patient, who was diagnosed with renal cell carcinoma (RCC) and presented with testicular metastasis at 5 years after the initial diagnosis, surgical interventions and systemic treatments. Although there are reports of testicular metastasis of RCC, to the best of our knowledge, our case is first who presented late recurrence in the testicular tissue despite previous tyrosine kinase inhibitor and PD1 inhibitor treatments.\",\"PeriodicalId\":42050,\"journal\":{\"name\":\"Journal of Urological Surgery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Urological Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/jus.galenos.2022.2022.0002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Urological Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/jus.galenos.2022.2022.0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
We report on a patient, who was diagnosed with renal cell carcinoma (RCC) and presented with testicular metastasis at 5 years after the initial diagnosis, surgical interventions and systemic treatments. Although there are reports of testicular metastasis of RCC, to the best of our knowledge, our case is first who presented late recurrence in the testicular tissue despite previous tyrosine kinase inhibitor and PD1 inhibitor treatments.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
